BDX wins FDA 510(k) clearance for the EnCor EnCompass breast biopsy system, set for an early 2026 launch to boost flexibility and patient care.

Galderma (SIX: GALD) will present ten posters with the latest updates from across its broad aesthetic portfolio spanning regenerative biostimulation, HA and neuromodulator treatments at the ...

Perhaps one of the most significant findings from BetterHelp's 2024 data is that 40% of new members were experiencing therapy ...

A significant winning streak of any kind in any sport is admirable, but to accomplish what the now 7th-ranked Nebraska men’s ...

Have you found your first therapist? Congrats! Now what? There are some rules for beginning the therapeutic work and ensuring ...

Click Therapeutics’ CEO discusses the first FDA-cleared depression app, migraine treatment breakthrough, and digital ...

In what may further escalate Afghanistan-Pakistan tensions, Kabul on Wednesday announced that medicines imported from the ...

Abbott has gained a CE mark in the European Union (EU) for the TactiFlex Duo ablation catheter, representing the company’s ...

Case counts remain far below the levels seen in 2022, but some experts are calling for research on the viability of an mpox ...

CEO of family company Angelini Industries will also lead the pharmaceutical company from today, bringing strong leadership ...

How a simple chart was stripped of context and turned into a symbol of fraud that outlived the news site that published it.